09:30AM 11/23/09
Director Magnuson Sells $9.5M Worth of Digital Realty Trust
Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.
10:01AM 11/17/09
Biotech Stock Mailbag: Poniard Predictions
Readers chime in on Poniard Pharmaceuticals, Chelsea Therapeutics, AMAG, Cel-Sci and Dendreon.
07:00AM 11/06/09
AMAG 3Q Loss Narrows Slightly On Anemia Drug Sales
AMAG Pharmaceuticals 3rd-quarter loss narrows on boost from sales of anemia drug Feraheme
10:42AM 10/29/09
AMAG Pharma Falls After Analyst Pares Rating
Analyst expects lower sales for AMAG Pharma's Feraheme, downgrades stock to 'Hold'
02:17PM 10/05/09
Investors Eye Vertex Hep C Competitor: BioBuzz
Is there a Hep C drug which can knock off Vertex's telaprevir?
11:04AM 10/05/09
Morning Playbook: Dividend.com
Brocade is strong on news that it may have put itself up for sale.
09:24AM 10/05/09
Seattle Genetics Halts Lymphoma Drug Study: BioBuzz
Drug deemed futile by independent data monitors, other trials continue
07:37AM 10/05/09
Biotech Mailbag: Cel-Sci, BioElectronics
Readers weigh in on Cel-Sci, BioElectronics, Dendreon, Cell Therapeutics and more.
09:18AM 10/02/09
Biotech Mailbag: Cel-Sci, BioElectronics
Readers weigh in on Cel-Sci, BioElectronics, Dendreon, Cell Therapeutics and more.
08:34AM 10/02/09
Biotech Mailbag: Cel-Sci, BioElectronics
Readers weigh in on Cel-Sci, BioElectronics, Dendreon, Cell Therapeutics and more.
06:56AM 10/02/09
Biotech Mailbag: Cel-Sci, BioElectronics (RealMoney.com $)
Readers weigh in on Cel-Sci, BioElectronics, Dendreon, Cell Therapeutics and more.
06:00AM 10/02/09
Spectrum Heeds Biotech's Golden Rule: BioBuzz
Raise money when you can it, not when you need it.
02:54PM 09/22/09
BioCryst and the Financially Limber Analyst: BioBuzz
One analyst uses valuation acrobatics to retain his BioCryst price target.
01:06PM 09/22/09
Dendreon Hot Going into Thursday's Investor Meeting: BioBuzz
Company expected to discuss all things Provenge
10:24AM 09/22/09



Connect with TheStreet